Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Key Movement
    • Granules India...

    Granules India Independent Director C Parthasarathy resigns

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2019-12-27T15:55:37+05:30  |  Updated On 27 Dec 2019 3:55 PM IST

    C Parthasarathy was serving the company since May 27, 2009. However, he submitted his resignation from the Board of Governors of Granules India Ltd. on 24th December 2019. His resignation was received by the company on December 26.


    Hyderabad: Hyderabad-based drugmaker, Granules India recently informed the bourses that C Parthasarathy has resigned as an independent director of the company, effective December 26 2019.


    Parthasarathy was serving the company since May 27, 2009. However, he submitted his resignation from the Board of Governors of Granules India Ltd. on 24th December 2019. His resignation was received by the company on December 26.


    Read Also: Granules India gets USFDA nod for allergy treatment drug Loratadine


    In his resignation letter, Parthasarathy said, “Further to the discussions that the undersigned had with your chairman and managing director C Krishna Prasad, I hereby tender my resignation from the board of governors of Granules India Ltd. I would be grateful if necessary formalities pertaining to my resignation are completed at the earliest and the details are intimated to me.”


    "I would like to thank the Chairman and Managing Director and Members of the Board for their warmth, support, and the mutual cooperation during my tenure on the Board," the letter added.


    Read Also: Granules India gets USFDA nod for Fexofenadine Hydrochloride tablets to treat allergy symptoms

    C Krishna PrasadC ParthasarathyGranulesgranules chairmanGranules Indiagranules mdParthasarathypharmapharma companypharma newsSEBI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok